Changes in bone mineral density in patients with recent onset, active rheumatoid arthritis

Annals of the Rheumatic Diseases

Volumn 67, Issue 6, 2008, Pages 823-828

  Guler Yuksel M ^a   Btjsterbosch, J ^a   Goekoop Ruiterman, Y P M ^a   De Vries Bouwstra, J K ^b   Hulsmans, H M J ^c   De Beus, W M ^d   Han, K H ^e   Breedveld, F C ^a   Dijkmans, B A C ^b,f,g   Allaart, C F ^a   Lems, W F ^b,f,g  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c HAGA HOSPITAL   (Netherlands)

^d MEDICAL CENTER HAAGLANDEN   (Netherlands)

^e Medisch Centrum Rijnmond Zuid   (Netherlands)

^f SLOTERVAART HOSPITAL   (Netherlands)

^g JAN VAN BREEMEN INSTITUTE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONIC ACID; CALCIUM; COLECALCIFEROL; HYDROXYCHLOROQUINE; INFLIXIMAB; LEFLUNOMIDE; METHOTREXATE; PREDNISONE; RISEDRONIC ACID; SALAZOSULFAPYRIDINE; STEROID;

ADD ON THERAPY; ADULT; ARTICLE; BONE DENSITOMETRY; BONE DENSITY; CALCIUM INTAKE; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DEMOGRAPHY; DISEASE ACTIVITY; DISEASE COURSE; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; FEMALE; FOLLOW UP; HIP; HORMONE SUBSTITUTION; HUMAN; JOINT INJURY; LUMBAR SPINE; MAJOR CLINICAL STUDY; MALE; MEDICAL PARAMETERS; MONOTHERAPY; MULTICENTER STUDY; MULTIPLE CYCLE TREATMENT; MULTIPLE REGRESSION; ONSET AGE; OSTEOLYSIS; OSTEOPOROSIS; PATHOGENESIS; PRIORITY JOURNAL; PROTECTION; RANDOMIZED CONTROLLED TRIAL; RHEUMATOID ARTHRITIS; SCORING SYSTEM; VITAMIN SUPPLEMENTATION;

ABSORPTIOMETRY, PHOTON; ADULT; AGED; ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; BONE DENSITY; BONE DENSITY CONSERVATION AGENTS; DIPHOSPHONATES; FEMALE; FOLLOW-UP STUDIES; GLUCOCORTICOIDS; HUMANS; LUMBAR VERTEBRAE; MALE; MIDDLE AGED; ODDS RATIO; OSTEOPOROSIS; PELVIC BONES; REGRESSION ANALYSIS; RISK; TUMOR NECROSIS FACTOR-ALPHA;

EID: 45149133490     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.2007.073817     Document Type: Article

References (45)

1. Westhovens R, Dequeker J. Rheumatoid arthritis and osteoporosis. Z Rheumatol 2000;59(suppl 1):33-8.
2. Green MJ, Deodhar AA. Bone changes in early rheumatoid arthritis. Best Pract Res Clin Rheumatol 2001;15:105-23.
3. Cooper C, Coupland C, Mitchell M. Rheumatoid arthritis, corticosteroid therapy and hip fracture. Ann Rheum Dis 1995;54:49-52.
4. Huusko TM, Korpela M, Karppi P, Avikainen V, Kautiainen H, Sulkava R. Threefold increased risk of hip fractures with rheumatoid arthritis in Central Finland. Ann Rheum Dis 2001;60:521-2.
5. Van Staa TP, Geusens P, Bijlsma JWJ, Leufkens HGM, Cooper C. Clinical assessment of the long-term risk of fracture in patients with rheumatoid arthritis. Arthritis Rheum 2006;54:3104-12.
6. Spector TD, Hall GM, McCloskey EV, Kanis JA. Risk of vertebral fracture in women with rheumatoid arthritis. BMJ 1993;306:558.
7. Peel NF, Moore DJ, Barrington NA, Bax DE, Eastell R. Risk of vertebral fracture and relationship to bone mineral density in steroid treated rheumatoid arthritis. Ann Rheum Dis 1995;54:801-6.
8. Buckley LM, Leib ES, Cartularo KS, Vacek PM, Cooper SM. Effects of low dose methotrexate on the bone mineral density of patients with rheumatoid arthritis. J Rheumatol 1997;24:1489-94.
9. Minaur NJ, Kounali D, Vedi S, Compston JE, Beresford JN, Bhalla AK. Methotrexate in the treatment of rheumatoid arthritis. II. In vivo effects of bone mineral density. Rheumatology 2002;41:741-9.
10. Di Munno O, Mazzantini M, Sinigaglia L, Bianchi G, Minisola G, Muratore M, et al. Effect of low dose methotrexate on bone density in women with rheumatoid arthritis: results from a multicenter cross-sectional study. J Rheumatol 2004;31:1305-9.
11. Dolan AL, Moniz C, Abraha H, Pitt P. Does active treatment of rheumatoid arthritis limit disease-associated bone loss? Rheumatology 2002;41:1047-51.
12. Sambrook PN, Cohen ML, Eisman JA, Pocock NA, Champion GD, Yeates MG. Effects of low dose corticosteroids on bone mass in rheumatoid arthritis: a longitudinal study. Ann Rheum Dis 1989;48:535-8.
13. Verhoeven AC, Boers M, te Koppele JM, van der Laan WH, Markusse HM, Geusens P, et al. Bone turnover, joint damage and bone mineral density in early rheumatoid arthritis treated with combination therapy including high-dose prednisone. Rheumatology 2001;40:1231-7.
14. Verhoeven AC, Boers M. Limited bone loss due to corticosteroids; a systematic review of prospective studies in rheumatoid arthritis and other diseases. J Rheumatol 1997;24:1495-503.
15. Habib GS, Haj S. Bone mineral density in patients with early arthritis treated with corticosteroids. Clin Rheumatol 2005;24:129-33.
16. Hall GM, Spector TD, Griffin AJ, Jawad AS, Hall ML, Doyle DV. The effect of rheumatoid arthritis and steroid therapy on bone density in postmenopausal women. Arthritis Rheum 1993;36:1510-16.
17. Haugeberg G, Strand A, Kvien TK, Kirwan JR. Reduced loss of hand bone density with prednisolone in early rheumatoid arthritis: results from a randomized placebo-controlled trial. Arch Intern Med 2005;165: 1293-7.
18. Vis M, Haavardsholm EA, Haugeberg G, Uhlig T, Voskuyl AE, van de Stadt RJ, et al. Evaluation of bone mineral density, bone metabolism, osteoprotegerin and RANKL serum levels during treatment with infliximab in patients with rheumatoid arthritis. Ann Rheum Dis 2006;65:1495-9.
19. Lange U, Teichmann J, Muller-ladner U, Strunk J. Increase in bone mineral density of patients with rheumatoid arthritis with anti-TNF-α antibody: a prospective open-label pilot study. Rheumatology 2005;44:1546-8.
20. Seriolo B, Paolino S, Sulli A, Ferretti V, Cutolo M. Bone metabolism changes during anti-TNF-α therapy in patients with active rheumatoid arthritis. Ann N Y Acad Sci 2006;1069:420-7.
21. Sambrook PN. The skeleton in rheumatoid arthritis; common mechanisms for bone erosion and osteoporosis? J Rheumatol 2000;27:2541-2.
22. Gravallese EM, Manning C, Tsay A, Naito A, Pan C, Amento E, et al. Synovial tissue in rheumatoid arthritis is a source of osteoclast differentiation factor. Arthritis Rheum 2000;43:250-8.
23. Takayanagi H, Iizuka H, Juji T, Nakagawa T, Yamamoto A, Miyazaki T, et al. Involvement of receptor activator of nuclear factor kappaB ligand/osteoclast differentiation factor in osteoclastogenesis from synoviocytes in rheumatoid arthritis. Arthritis Rheum 2000;43:259-69.
24. Hofbauer LC, Khosla S, Dunstan CR, Lacey DL, Boyle WJ, Riggs BL. The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption. J Bone Miner Res 2000;15:2-12.
25. Geusens PP, Landewe RBM, Garnero P, Chen D, Dunstan CR, Lems WF, et al. The ratio of circulating osteoprotegerin to RANKL in early rheumatoid arthritis predicts later joint destruction. Arthritis Rheum 2006;54:1772-7.
26. Forslind K, Keller C, Svensson B, Hafstrom I. Reduced bone mineral density in early rheumatoid arthritis is associated with radiological joint damage at baseline and after 2 years in women. J Rheumatol 2003;30:2590-6.
27. Cortet B, Guyot MH, Solau E, Pigny P, Dumoulin F, Flipo RM, et al. Factors influencing bone loss in rheumatoid arthritis: a longitudinal study. Clin Exp Rheumatol 2000;18:683-90.
28. Gough AK, Lilley J, Eyre S, Holder RL, Emery P. Generalised bone loss in patients with early rheumatoid arthritis. Lancet 1994;344:23-7.
29. Shenstone BD, Mahmoud A, Woodward R, Elvins D, Palmer R, Ring EF, et al. Longitudinal bone mineral density changes in early rheumatoid arthritis. Br J Rheumatol 1994;33:541-5.
30. Clinical practice guidelines for the diagnosis and management of osteoporosis. Scientific Advisory Board, Osteoporosis Society of Canada. CMAJ 1996;155:1113-33.
31. Boulos P, Adachi JD. Guidelines for the prevention and the therapy of glucocorticoid-induced osteoporosis. Clin Exp Rheumatol 2000;18:79-86.
32. Buckley LM, Leib ES, Cartularo KS, Vacek PM, Cooper SM. Calcium and vitamin D3 supplementation prevents bone loss in the spine secondary to low-dose corticosteroids in patients with rheumatoid arthritis. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 1996;125:961-8.
33. Adachi JD, Ioannidis G. Calcium and vitamin D therapy in corticosteroid-induced bone loss: What is the evidence? Calcif Tissue Int 1999;65:332-6.
34. Sambrook PN. How to prevent steroid induced osteoporosis. Ann Rheum Dis 2005;64:176-8.
35. Goekoop-Ruiterman YP, Vries-Bouwstra JK, Allaart CF, van Zeben D, Kerstens PJ, Hazes JM, et al. Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): a randomized, controlled trial. Arthritis Rheum 2005;52:3381-90.
36. Pocock NA, Noakes KA, Griffiths M, Bhalerao H, Sambrook PN, Eisman JA, et al. A comparison of longitudinal measurements in the spine and proximal femur using lunar and hologic instruments. J Bone Miner Res 1997;12:2113-18.
37. Jun Zhang MB, Kai F Yu. What's the relative risk? JAMA 1998;280:1690-91.
38. Burger H, de Laet CE, van Daele PL, Weel AE, Witteman JC, Hofman A, et al. Risk factors for increased bone loss in an elderly population: the Rotterdam Study. Am J Epidemiol 1998;147:871-9.
39. Haugeberg G, Orstavik RE, Uhlig T, Falch JA, Halse Jl, Kvien TK. Bone loss in patients with rheumatoid arthritis: results from a population-based cohort of 366 patients followed up for two years. Arthritis Rheum 2002;46:1720-8.
40. Kroot EJ, Nieuwenhuizen MG, Waal Malefijt MC, van Riel PL, Pasker-de Jong PC, Laan RF. Change in bone mineral density in patients with rheumatoid arthritis during the first decade of the disease. Arthritis Rheum 2001;44:1254-60.
41. Aman S, Hakala M, Silvennoinen J, Manelius J, Risteli L Risteli J. Low incidence of osteoporosis in a two year follow-up of early community based patients with rheumatoid arthritis. Scand J Rheumatol 1998;27:188-93.
42. Jensen T, Klarlund M, Hansen M, Jensen KE, Podenphant J, Hansen TM, et al, the TIRA Group. Bone loss in unclassified polyarthritis and early rheumatoid arthritis is better detected by digital x ray radiogrammetry than dual x ray absorptiometry: relationship with disease activity and radiographic outcome. Ann Rheum Dis 2004;63:15-22.
43. Adachi JD, Bensen WG, Brown J, Hanley D, Hodsman A, Josse R, et al. Intermittent etidronate therapy to prevent corticosteroid-induced osteoporosis. N Engl J Med 1997;337:182-7.
44. Saag KG, Emkey R, Schnitzer TJ, Brown JP, Hawkins F, Goemaere S, et al, for the Glucocorticoid-Induced Osteoporosis Intervention Study Group. Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis. N Engl J Med 1998;339:292-9.
45. Cohen S, Levy RM, Keller M, Boling E, Emkey RD, Greenwald M, et al. Risedronate therapy prevents glucocorticosteroid-induced bone loss: a twelve-month, multicenter, randomized, double-blind, placebo-controlled, parallel-group study. Arthritis Rheum 1999;42:2309-18.